Cargando…
Genome editing via non-viral delivery platforms: current progress in personalized cancer therapy
Cancer is a severe disease that substantially jeopardizes global health. Although considerable efforts have been made to discover effective anti-cancer therapeutics, the cancer incidence and mortality are still growing. The personalized anti-cancer therapies present themselves as a promising solutio...
Autores principales: | Lan, Tianxia, Que, Haiying, Luo, Min, Zhao, Xia, Wei, Xiawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915502/ https://www.ncbi.nlm.nih.gov/pubmed/35277177 http://dx.doi.org/10.1186/s12943-022-01550-8 |
Ejemplares similares
-
Inflammatory Cytokines in Cancer: Comprehensive Understanding and Clinical Progress in Gene Therapy
por: Lan, Tianxia, et al.
Publicado: (2021) -
Current Progress of Mitochondrial Genome Editing by CRISPR
por: Yin, Tao, et al.
Publicado: (2022) -
Mesenchymal stem/stromal cells in cancer therapy
por: Lan, Tianxia, et al.
Publicado: (2021) -
Nanomaterial-Based Drug Delivery System Targeting Lymph Nodes
por: Cheng, Zesheng, et al.
Publicado: (2022) -
Inhibition of 15-PDGH: a strategy to rejuvenate aged muscles?
por: Lan, Tianxia, et al.
Publicado: (2021)